Prolia denied as non-formulary by UnitedHealthcare?

UnitedHealthcare's specific coverage criteria for prolia are defined in its own published medical/coverage policy and the FDA-approved prescribing label. A successful appeal documents that your medical records satisfy each criterion those sources list — confirmed diagnosis, any required prior treatments (with dates and outcomes), and clinical severity. If the exact criteria weren't included with your denial, request them in writing; your appeal then maps each requirement to the matching fact in your chart.

## Why UnitedHealthcare Denies Prolia as Non-Formulary

UnitedHealthcare places Prolia (denosumab) on its formulary at a tier that requires prior authorization, and in some plan designs Prolia may be excluded from certain formulary tiers or benefit categories unless specific clinical criteria are met. A non-formulary denial may reflect that the plan's preferred osteoporosis agents have not been documented as tried and failed, or that Prolia falls on a non-preferred tier for which a formulary exception must be separately requested. The specific formulary tier and exception criteria vary by employer plan design and UHC formulary version.

## Why This Denial Is Appealable

Formulary placement does not end the inquiry. UHC plans allow formulary exceptions when the preferred or lower-tier agents are clinically inappropriate, have been tried and produced an inadequate response, or are not suitable for the specific patient. If the prescriber can document that Prolia is necessary for reasons tied to the individual patient's clinical history — including prior-agent failure, intolerance, or a clinical context in which alternatives are not appropriate — a formulary exception is the correct pathway. Exceptions that are denied are themselves subject to internal and external appeal.

## Federal Appeal Framework

• Formulary exception request: File a formulary exception simultaneously with or before the internal appeal. The exception pathway is often faster and involves a lower evidentiary threshold than a full medical-necessity appeal.
• Internal appeal (ACA §2719): A non-formulary denial is an adverse benefit determination. You are entitled to at least one internal appeal with a written decision citing the specific criteria not met.
• ERISA §503: For employer-sponsored plans, ERISA entitles you to the full claims file and the formulary exception criteria used in the determination.
• External review: After exhausting internal review, ACA §2719 external review by an independent organization is available. External reviewers assess clinical appropriateness and are not bound by UHC's formulary tier structure.
• Timeline: External review requests are typically due within four months of the final adverse internal decision. Expedited review is available when the standard timeline would seriously jeopardize health.

## Documents to Gather

• Preferred-agent trial records: Documentation of any UHC-preferred osteoporosis agents that were tried, with specific dates, duration, and the clinical outcome (inadequate response, adverse event, or reason for discontinuation). Obtain exact agent names and tier designations from the current UHC formulary for your plan.
• Clinical contraindication or intolerance statement: If preferred agents have not been tried because they are clinically inappropriate for this patient, a prescriber letter explaining the specific clinical reasons.
• Prescriber medical-necessity letter: A letter addressing UHC's formulary exception criteria by name, explaining why Prolia is necessary and why formulary alternatives are insufficient for this patient.
• UHC formulary and exception policy: Obtain the specific formulary document applicable to your plan (by plan year and group number) and UHC's published formulary exception criteria. These define exactly what must be demonstrated for an exception to be granted.

## Criteria-Mapping Structure

Create a table mapping each formulary exception criterion from UHC's policy to the specific supporting evidence: left column lists the requirement verbatim; right column cites the chart entry, letter section, or supplier record satisfying it. Attach this as an exhibit to the exception request and any subsequent appeal. Demonstrating that every criterion is addressed eliminates the plan's basis for a blanket non-formulary denial.